Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Equity Ratio (2016 - 2025)

CorMedix has reported Equity Ratio over the past 15 years, most recently at 0.49 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.49 for Q4 2025, down 31.13% from a year ago — trailing twelve months through Dec 2025 was 0.49 (down 31.13% YoY), and the annual figure for FY2025 was 0.49, down 31.13%.
  • Equity Ratio reached 0.49 in Q4 2025 per CRMD's latest filing, down from 0.5 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.95 in Q1 2021 and bottomed at 0.49 in Q4 2025.
  • Median Equity Ratio over the past 5 years was 0.88 (2022), compared with a mean of 0.83.
  • Peak annual rise in Equity Ratio hit 24.41% in 2021, while the deepest fall reached 88.26% in 2021.
  • Over 5 years, Equity Ratio stood at 0.91 in 2021, then decreased by 2.56% to 0.89 in 2022, then decreased by 3.69% to 0.85 in 2023, then fell by 16.66% to 0.71 in 2024, then plummeted by 31.13% to 0.49 in 2025.
  • Business Quant data shows Equity Ratio for CRMD at 0.49 in Q4 2025, 0.5 in Q3 2025, and 0.87 in Q2 2025.